Our Plug and Play Technology allows production of antibodies with a wide possibility of uses.
Based on our plug-and-play antibody platform, we can provide high titer IgY to virtually any antigen of interest. We have completed antibody productions for prestigious research organizations such as Mayo Clinic and USAMRIID.
Currently we are seeking product licensure for our therapeutic antibody against Canine Parvovirus. Future veterinary targets include: PEDv and Bovine Corona/Rotavirus.
We have completed pre-IND research work and have reached TRL-5 status in a wide variety of disease targets. Currently, we are preparing for Stage 1 clinical trials against Andes virus.